An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands (<scp>PD</scp>‐L1/2) on infiltrating macrophages in lymphoma

Hasita Horlad, Chaoya Ma, Hiromu Yano, +9

Cancer Science

High density of <scp>CD</scp>204‐positive macrophages predicts worse clinical prognosis in patients with breast cancer

Yuko Miyasato, Takuya Shiota, Koji Ohnishi, +8

Cancer Science

SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma

Eri Matsubara, Yoshihiro Komohara, Shigeyuki Esumi, +10

Cancers

Tumor-associated MacrophagesLung InflammationLung AdenocarcinomaImmunologyPathology +14

Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, +10

Proceedings of the National Academy of Sciences

The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma

Yuko Miyasato, Yasuo Takashima, Hiroto Takeya, +7

Journal of Clinical and Experimental Hematopathology

ImmunologyPathologyCell DeathImmunotherapyGlioma +18

The Characteristics of Mediastinal Neuroblastoma

S. Suita, Tatsuro Tajiri, Yasunori Sera, +14

European Journal of Pediatric Surgery

N-myc AmplificationTumoral PathologyTumor InnervationMedicineSurgical Pathology +10

Clinical importance of extraordinary integration patterns of human T- cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma [see comments]

Yoshinori Shimamoto, Kenji Suga, Keisuke Shibata, +3

Blood

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration

Sho Kawaguchi, Kenta Kawahara, Yukio Fujiwara, +18

Cancer Immunology Immunotherapy

Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan

Sachiyo Suita, Yoshio Zaizen, Yasunori Sera, +13

Journal of Pediatric Surgery

Mass ScreeningPediatric Brain TumorsQuo VadisPediatric NeurosurgeryMedicine +9

Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines

Chaoya Ma, Hasita Horlad, Cheng Pan, +9

Journal of Clinical and Experimental Hematopathology

Lymphoid NeoplasiaRadiation OncologyCancer ImmunosurveillancePd-1 LigandsImmunology +12